Sponsor or institution
Clinical trials and research at 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
As of November 12, 2026, Find a Trial lists 6 clinical trials run by 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China that are recruiting, in China. By phase: Early Phase 1 (2), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| JY231 injection for relapsed or refractory CD19-positive B-cell malignancies | — | Kunming, Yunnan | Recruiting | Jul 15, 2025 |
| Evaluating a new CAR-T cell therapy for advanced solid tumors with CDH17 expression | Early Phase 1 | Kunming, Yunnan | Recruiting | Feb 11, 2025 |
| JY231 injection for treating active systemic lupus erythematosus | Phase 1/2 | Kunming, Yunnan | Recruiting | Nov 5, 2024 |
| Treatment of relapsed or refractory multiple myeloma using CAR-T cells | — | Kunming, Kunming, Yunnan | Recruiting | Jul 23, 2024 |
| JY231 injection for treating B-cell acute lymphoblastic leukemia | Early Phase 1 | Kunming, Yunnan | Recruiting | Jul 23, 2024 |
| CAR-T cell therapy for chronic or refractory immune thrombocytopenia | Phase 1/2 | Kunming, Yunnan | Recruiting | Apr 8, 2024 |
All recruiting trials (6)
-
JY231 injection for relapsed or refractory CD19-positive B-cell malignancies
This trial will test whether a single intravenous injection of JY231, an in vivo CAR-T therapy, can help adults with relapsed or refractory CD19-positive B-cell malignancies.
-
Evaluating a new CAR-T cell therapy for advanced solid tumors with CDH17 expression
This study is testing a new CAR-T cell therapy to see if it can help people with advanced solid tumors that have a specific marker called CDH17.
-
JY231 injection for treating active systemic lupus erythematosus
This study is testing a new injection called JY231 to see if it can safely help people with active lupus who have already tried other treatments.
-
Treatment of relapsed or refractory multiple myeloma using CAR-T cells
This study is testing a new CAR-T cell treatment for people with relapsed or refractory multiple myeloma who have already tried three or more therapies to see if it can help them.
-
JY231 injection for treating B-cell acute lymphoblastic leukemia
This study is testing a new injection called JY231 to see if it can safely help people with B-cell acute lymphoblastic leukemia feel better.
-
CAR-T cell therapy for chronic or refractory immune thrombocytopenia
This study is testing if CAR-T cell therapy can help people with chronic or hard-to-treat immune thrombocytopenia improve their platelet counts and overall health.
Quick answers
How many clinical trials run by 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.